28 October 2025
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives Orphan Drug Designation in the EU GSK plc (LSE/NYSE: GSK) today announced that GSK5764227 (GSK’227), its B7-H3-targeted antibody-drug conjugate…
B.P. Marsh & Partners Plc (“B.P. Marsh”, “the Company” or “the Group”) Sale of Stewart Specialty Risk Underwriting Limited B.P. Marsh & Partners Plc…
COLEFAX GROUP PLC (the “Company”) Result of Tender Offer Purchase of Own Shares and Total Voting Rights The Company (AIM:CFX) is pleased to announce…
27 October 2025
LSEG and Anthropic collaborate to make more financial dataaccessible to Claude for Enterprise customers LSEG today announced a collaboration with Anthropic granting access to…
GOODWIN PLC October 2025 Trading Update Further to the Trading Update on 24th September, and in light of the strong trading performance across the businesses,…
24 October 2025
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration…
23 October 2025
Coca-Cola HBCAcquisition of Coca-Cola Beverages Africa, bringing together two leading bottlers in Africa to drivesustainable, profitable growth Zug, Switzerland, 21 October 2025. Coca-Cola HBC…
KEY QUARTERLY HIGHLIGHTS Macroeconomic volatility persisted as anticipated and became more pronounced in the third quarter, creating a challenging environment, resulting in a mixed…